Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 and Vitamin D in Childhood Type 1 Diabetes
NCT03911843Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Phase 3, open-label trial of omega-3 fatty acid in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Primary endpoints: Daily Insulin Need at 12 months, Glycosylated Hemoglobin Percentage at 12 months and 1 more. Started Jan 2017; status: completed.
02
Drugs
omega-3 fatty acid
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03911843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03911843.